Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ('CSPC') (Stock Code: 1093.HK) jointly announced that anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 has ...

New data from the Phase II RAINFOL-01 study shows rinatabart sesutecan (Rina-S), an investigative antibody-drug conjugate, ...

Real Housewives of Beverly Hills alum Teddi Mellencamp shared a health update with her followers as she gets treated for multiple brain tumors in her brain and lungs.

Jon Baptiste revealed that his wife Suleika Jaouad is "doing great" amid her cancer going into remission again during an ...

AbbVie's Elahere maintains strong efficacy in the Phase 3 MIRASOL trial for ovarian cancer, with durable survival benefits ...

Imagine a world where bacteria, typically feared for causing disease, are turned into powerful weapons against cancer. That's ...

Glioblastoma has remained one of the toughest cancers to treat, resisting even the latest advances in immunotherapy.

Media ReleaseCOPENHAGEN, Denmark; March 17, 2025 Results from Phase 2 RAINFOLTM-01 trial (B1 cohort) showed that with a median on-study follow-up of 48 weeks, Rina-S 120 mg/m2 led to a confirmed objec ...

Results from Phase 2 RAINFOLTM-01 trial (B1 cohort) showed that with a median on-study follow-up of 48 weeks, Rina-S 120 mg/m2 led to a confirmed objective response rate (ORR) of 55.6% and median ...

We’re using evolution to attack tumors,” said study senior author, Ashish H. Shah, M.D. Viral mimicry was first successfully used to make ovarian cancer more susceptible to ICI in 2015. It has since ...

Elizabeth K. Lee, MD, a medical oncologist in the gynecologic oncology program at Dana-Farber, presented results from a phase ...

Glioblastoma has long resisted treatment, but scientists may have found a breakthrough by leveraging the body's own ...